A new multimodal AI model helps solve the agonizing clinical dilemma of whether breast cancer survivors should endure five extra years of hormone therapy.
Clinical calculators dictate life-or-death medical decisions every day, but doctors have had no objective way to know which algorithms are actually safe to trust.
A new algorithm spots rare growth disorders years before traditional clinical methods, shifting the focus of pediatric screening from reactive tracking to active prediction.